Literature DB >> 30874233

Determination of Risk Factors in Children Diagnosed With Henoch-Schönlein Purpura.

Beltinge Demircioğlu Kiliç1, Belde Kasap Demir2.   

Abstract

OBJECTIVES: This study aims to evaluate the frequency of skin, gastrointestinal, joint, and renal involvement in children with Henoch-Schönlein purpura and investigate the risk factors for organ/system involvement. PATIENTS AND METHODS: The data of 186 patients (97 boys, 89 girls; mean age 7.4±2.8 years; range 1.5 to 16.5 years) who were followed-up with the diagnosis of Henoch-Schönlein purpura in our clinic between October 2011 and December 2013 were evaluated retrospectively.
RESULTS: Logistic regression analysis revealed that the risk of gastrointestinal system involvement was significantly higher in patients with skin lesions in the upper extremities (p=0.002, odds ratio [OR]=3.2). The risk of joint involvement was significantly higher in girls (p=0.024, OR=2.18), in patients with soft tissue swelling (p=0.005, OR=2.63), and with low mean platelet volume levels (p=0.008, OR=4.07). The risk of renal involvement was significantly higher in girls (p=0.047, OR=2.7), in patients >10 years (p=0.001, OR=1.4), and in patients with elevated C-reactive protein levels (p=0.007, OR=6.57).
CONCLUSION: Having skin lesions in the upper extremities is a risk factor for gastrointestinal system involvement. Female sex, soft tissue swelling, and low mean platelet volume levels are risk factors for joint involvement. Female sex, >10 years of age, and high C-reactive protein levels are risk factors for renal involvement. Renal involvement in Henoch-Schönlein purpura is independent of gastrointestinal system or joint involvement and very close follow-up is required in the acute period particularly in girls >10 years with high C-reactive protein levels.

Entities:  

Keywords:  Children; Henoch-Schönlein purpura; organ/system involvement; risk factors

Year:  2018        PMID: 30874233      PMCID: PMC6409163          DOI: 10.5606/ArchRheumatol.2018.6562

Source DB:  PubMed          Journal:  Arch Rheumatol        ISSN: 2148-5046            Impact factor:   1.472


  36 in total

1.  Risk factors of renal involvement and significant proteinuria in Henoch-Schönlein purpura.

Authors:  Hitomi Sano; Michiko Izumida; Hiroshi Shimizu; Yunosuke Ogawa
Journal:  Eur J Pediatr       Date:  2002-04       Impact factor: 3.183

Review 2.  The spectrum of vasculitis in children.

Authors:  S Ozen
Journal:  Best Pract Res Clin Rheumatol       Date:  2002-07       Impact factor: 4.098

Review 3.  Acute scrotum caused by Henoch-Schönlein purpura.

Authors:  Yoshinori Hara; Takehiro Tajiri; Kenichi Matsuura; Akio Hasegawa
Journal:  Int J Urol       Date:  2004-07       Impact factor: 3.369

4.  EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides.

Authors:  S Ozen; N Ruperto; M J Dillon; A Bagga; K Barron; J C Davin; T Kawasaki; C Lindsley; R E Petty; A M Prieur; A Ravelli; P Woo
Journal:  Ann Rheum Dis       Date:  2005-12-01       Impact factor: 19.103

5.  Henoch Schonlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature.

Authors:  Sandra Trapani; Annalisa Micheli; Francesca Grisolia; Massimo Resti; Elena Chiappini; Fernanda Falcini; Maurizio De Martino
Journal:  Semin Arthritis Rheum       Date:  2005-12       Impact factor: 5.532

6.  Clinical outcome in children with Henoch-Schönlein nephritis.

Authors:  Sevgi Mir; Onder Yavascan; Fatma Mutlubas; Betul Yeniay; Ferah Sonmez
Journal:  Pediatr Nephrol       Date:  2006-09-21       Impact factor: 3.714

7.  Henoch-Schönlein's purpura in adults versus children/adolescents: A comparative study.

Authors:  S S Uppal; M A S Hussain; H A Al-Raqum; M R N Nampoory; K Al-Saeid; A Al-Assousi; M Abraham; A N Malaviya
Journal:  Clin Exp Rheumatol       Date:  2006 Mar-Apr       Impact factor: 4.473

8.  Incidence of vasculitis in children in the Czech Republic: 2-year prospective epidemiology survey.

Authors:  Pavla Dolezalová; Petra Telekesová; Dana Nemcová; Jozef Hoza
Journal:  J Rheumatol       Date:  2004-11       Impact factor: 4.666

9.  Childhood vasculitides in Turkey: a nationwide survey.

Authors:  Seza Ozen; Aysin Bakkaloglu; Ruhan Dusunsel; Oguz Soylemezoglu; Fatih Ozaltin; Hakan Poyrazoglu; Ozgur Kasapcopur; Ozan Ozkaya; Fatos Yalcinkaya; Ayse Balat; Nurdan Kural; Osman Donmez; Harika Alpay; Ali Anarat; Sevgi Mir; Ayfer Gur-Guven; Ferah Sonmez; Faysal Gok
Journal:  Clin Rheumatol       Date:  2006-04-04       Impact factor: 2.980

10.  Outcome of Henoch-Schoenlein nephritis with nephrotic-range proteinuria.

Authors:  J Ronkainen; M Ala-Houhala; N P Huttunen; T Jahnukainen; O Koskimies; T Ormälä; M Nuutinen
Journal:  Clin Nephrol       Date:  2003-08       Impact factor: 0.975

View more
  5 in total

1.  Predictive Value of Laboratory Indexes on Renal Involvement in Children with Henoch-Schönlein Purpura.

Authors:  Leying Xi; Shuang Xu; Yingying Jiang; Hang Su; Yuying Sun; Yingying Wen; Jingjing Wu; Xianqing Ren
Journal:  Int J Gen Med       Date:  2021-11-09

2.  Construction and internal validation of a predictive model for risk of gastrointestinal bleeding in children with abdominal Henoch-Schönlein purpura: A single-center retrospective case-control study.

Authors:  Lingli Sun; Wenjuan Liu; Changjian Li; Yong Zhang; Yuanyuan Shi
Journal:  Front Immunol       Date:  2022-09-29       Impact factor: 8.786

3.  Hemorrhagic rash on the legs.

Authors:  Stephan Traidl; Yenny Angela; Alexander Kapp; Matthias Schefzyk
Journal:  JAAD Case Rep       Date:  2021-04-24

4.  Clinico-Epidemiological Profile and Outcome of Children with IgA Vasculitis in Aseer Region, Southwestern Saudi Arabia.

Authors:  Samy A Dawood; Abdoh M Abodiah; Saleh M Alqahtani; Ayed A Shati; Youssef A Alqahtani; Mohammed A Alshehri; Syed E Mahmood
Journal:  Healthcare (Basel)       Date:  2021-12-07

5.  Risk factors for renal involvement in Henoch-Schönlein purpura.

Authors:  Woo Kyung Kim; Chan Jong Kim; Eun Mi Yang
Journal:  J Pediatr (Rio J)       Date:  2021-03-12       Impact factor: 2.990

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.